These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 7904976)
1. Neuropsychopharmacological profile in rodents of SR 57746A, a new, potent 5-HT1A receptor agonist. Simiand J; Keane PE; Barnouin MC; Keane M; Soubrié P; Le Fur G Fundam Clin Pharmacol; 1993; 7(8):413-27. PubMed ID: 7904976 [TBL] [Abstract][Full Text] [Related]
2. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties. Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550 [TBL] [Abstract][Full Text] [Related]
3. Potential antidepressant properties of SR 57746A, a novel compound with selectivity and high affinity for 5-HT1A receptors. Cervo L; Bendotti C; Tarizzo G; Cagnotto A; Skorupska M; Mennini T; Samanin R Eur J Pharmacol; 1994 Feb; 253(1-2):139-47. PubMed ID: 8013540 [TBL] [Abstract][Full Text] [Related]
4. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia. Park WK; Jeong D; Cho H; Lee SJ; Cha MY; Pae AN; Choi KI; Koh HY; Kong JY Pharmacol Biochem Behav; 2005 Oct; 82(2):361-72. PubMed ID: 16216322 [TBL] [Abstract][Full Text] [Related]
5. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635. de Boer SF; Lesourd M; Mocaer E; Koolhaas JM J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850 [TBL] [Abstract][Full Text] [Related]
6. Biochemical and electrophysiological properties of SR 57746A, a new, potent 5-HT1A receptor agonist. Bachy A; Steinberg R; Santucci V; Fournier M; Landi M; Hamon M; Manara L; Keane PE; Soubrié P; Le Fur G Fundam Clin Pharmacol; 1993; 7(9):487-97. PubMed ID: 8314196 [TBL] [Abstract][Full Text] [Related]
7. Antidepressant-like properties of some serotonin receptor ligands and calcium channel antagonists measured with the forced swimming test in mice. Biała G Pol J Pharmacol; 1998; 50(2):117-24. PubMed ID: 9798263 [TBL] [Abstract][Full Text] [Related]
8. Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates. Fournier J; Steinberg R; Gauthier T; Keane PE; Guzzi U; Coudé FX; Bougault I; Maffrand JP; Soubrié P; Le Fur G Neuroscience; 1993 Aug; 55(3):629-41. PubMed ID: 8413926 [TBL] [Abstract][Full Text] [Related]
9. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity. Dawson LA; Hughes ZA; Starr KR; Storey JD; Bettelini L; Bacchi F; Arban R; Poffe A; Melotto S; Hagan JJ; Price GW Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092 [TBL] [Abstract][Full Text] [Related]
10. Effects of 8-OH-DPAT and ipsapirone in the tests used for evaluation of the antidepressant action. Tatarczyńska E; Chojnacka-Wójcik E Pol J Pharmacol Pharm; 1989; 41(4):321-30. PubMed ID: 2534521 [TBL] [Abstract][Full Text] [Related]
11. Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor. Chaki S; Hirota S; Funakoshi T; Suzuki Y; Suetake S; Okubo T; Ishii T; Nakazato A; Okuyama S J Pharmacol Exp Ther; 2003 Feb; 304(2):818-26. PubMed ID: 12538838 [TBL] [Abstract][Full Text] [Related]
12. Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors. Martínez-Mota L; Estrada-Camarena E; López-Rubalcava C Psychopharmacology (Berl); 2002 Dec; 165(1):60-6. PubMed ID: 12474119 [TBL] [Abstract][Full Text] [Related]
14. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis. de Boer SF; Koolhaas JM Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183 [TBL] [Abstract][Full Text] [Related]
15. Some pharmacological properties of new analogs of MP 3022, the 5-HT1A receptor antagonist. Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E; Paluchowska MH Pol J Pharmacol; 1999; 51(5):405-13. PubMed ID: 10817541 [TBL] [Abstract][Full Text] [Related]
16. The effect of the nonpeptide neurotrophic compound SR 57746A on the progression of the disease state of the pmn mouse. Duong F; Fournier J; Keane PE; Guénet JL; Soubrié P; Warter JM; Borg J; Poindron P Br J Pharmacol; 1998 Jun; 124(4):811-7. PubMed ID: 9690875 [TBL] [Abstract][Full Text] [Related]